Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect by Rahman, Heshu Sulaiman et al.
Zerumbone-loaded nanostructured lipid carriers: preparation, characterization and 
antileukemic effect 
 
ABSTRACT 
Zerumbone, a natural dietary lipophilic compound with low water solubility (1.296 mg/L at 
25°C) was used in this investigation. The zerumbone was loaded into nanostructured lipid 
carriers using a hot, high-pressure homogenization technique. The physicochemical 
properties of the zerumbone-loaded nanostructured lipid carriers (ZER-NLC) were 
determined. The ZER-NLC particles had an average size of 52.68 ± 0.1 nm and a 
polydispersity index of 0.29 ± 0.004 μm. Transmission electron microscopy showed that the 
particles were spherical in shape. The zeta potential of the ZER-NLC was −25.03 ± 1.24 mV, 
entrapment efficiency was 99.03%, and drug loading was 7.92%. In vitro drug release of 
zerumbone from ZER-NLC was 46.7%, and for a pure zerumbone dispersion was 90.5% over 
48 hours, following a zero equation. Using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay in human T-cell acute lymphoblastic leukemia (Jurkat) 
cells, the half maximal inhibitory concentration (IC50) of ZER-NLC was 5.64 ± 0.38 μg/mL, 
and for free zerumbone was 5.39 ± 0.43 μg/mL after 72 hours of treatment. This study 
strongly suggests that ZER-NLC have potential as a sustained-release drug carrier system for 
the treatment of leukemia. 
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